Mantle cell lymphoma risk factors

Jump to navigation Jump to search

Mantle cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mantle cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mantle cell lymphoma risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mantle cell lymphoma risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mantle cell lymphoma risk factors

on Mantle cell lymphoma risk factors

Mantle cell lymphoma risk factors in the news

Blogs on Mantle cell lymphoma risk factors

Directions to Hospitals Treating Mantle cell lymphoma

Risk calculators and risk factors for Mantle cell lymphoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2] Sowminya Arikapudi, M.B,B.S. [3]

Overview

There are no established risk factors for mantle cell lymphoma. However, recently weak associations have been observed in the development of mantle cell lymphoma such as the exposure to European strains of Borrelia burgdorferi, family history of hematologic malignancy, and genetic polymorphisms in the pro-inflammatory cytokine IL-10.

Risk Factors

References

  1. Schöllkopf C, Melbye M, Munksgaard L, Smedby KE, Rostgaard K, Glimelius B; et al. (2008). "Borrelia infection and risk of non-Hodgkin lymphoma". Blood. 111 (12): 5524–9. doi:10.1182/blood-2007-08-109611. PMC 2972577. PMID 18424667.
  2. Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L; et al. (2007). "Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)". Blood. 109 (8): 3479–88. doi:10.1182/blood-2006-06-031948. PMC 1852242. PMID 17185468.
  3. Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S, Hughes AM; et al. (2010). "Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium". Am J Epidemiol. 171 (3): 267–76. doi:10.1093/aje/kwp383. PMC 2842204. PMID 20047977.

Template:Hematology

Template:WH Template:WS